help button home button The Oncologist http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

The Oncologist, Vol. 12, No. 9, 1055-1066, September 2007; doi:10.1634/theoncologist.12-9-1055
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oktay, K.
Right arrow Articles by Bang, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oktay, K.
Right arrow Articles by Bang, H.

Breast Cancer

Absence of Conclusive Evidence for the Safety and Efficacy of Gonadotropin-Releasing Hormone Analogue Treatment in Protecting Against Chemotherapy-Induced Gonadal Injury

Kutluk Oktaya, Murat Sönmezerb, Özgür Öktema, Kevin Foxc, Günter Emonsd, Heejung Bange

aDepartment of Obstetrics and Gynecology, Joan and Sanford I. Weill Medical College of Cornell University, New York, New York, USA; bDepartment of Obstetrics and Gynecology, Ankara University School of Medicine, Ankara, Turkey; cRena Rowan Breast Center, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA; dDepartment of Obstetrics & Gynecology, University of Göttingen, Göttingen, Germany; eDivision of Biostatistics and Epidemiology, Department of Public Health, Weill Medical College of Cornell University, New York, New York, USA

Key Words. Chemotherapy • GnRH analogues • Ovarian damage

Correspondence: Correspondence: Kutluk Oktay, M.D., Department of Obstetrics and Gynecology, Joan and Sanford I. Weill Medical College of Cornell University, 505 East 70th Street, HT-340, New York, New York 10021, USA. Telephone: 212-746-4292; Fax: 212-746-5929; e-mail: Koktay{at}fertilitypreservation.org

Disclosure: No potential conflicts of interest were reported by the authors, planners, reviewers, or staff managers of this article.

Every year, an increasing number of women with malignant and nonmalignant diseases is successfully treated with cytotoxic chemotherapy and/or radiotherapy. Many of these patients suffer from infertility and gonadal failure as a result of these treatments. At present, these patients may resort to assisted-reproduction techniques to protect their future childbearing potential before the implementation of cytotoxic therapy. While embryo cryopreservation is an established technology, oocyte and ovarian tissue freezing techniques are still investigational. Nevertheless both of these techniques have resulted in live births. Apart from assisted-reproduction techniques, it has been extensively debated whether administration of gonadotropin-releasing hormone (GnRH) analogues in conjunction with chemotherapy can protect ovarian reserve against cytotoxic insult. In this manuscript, we debate the rationale for the effectiveness of GnRH analogue coadministration in preservation of fertility by reviewing the literature, and provide preliminary data to support our views.




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
S. E. Elizur, R. C. Chian, C. A. Pineau, W. Y. Son, H. E. G. Holzer, J. Y. J. Huang, Y. Gidoni, D. Levin, E. Demirtas, and S. L. Tan
Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents
Rheumatology, July 26, 2008; (2008) ken293v1.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Costa and D. Colia
Treating infertility in autoimmune patients
Rheumatology, June 1, 2008; 47(suppl_3): iii38 - iii41.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
E. C. Somers, G. M. Christman, S. Fisseha, W. Marder, and W. J. McCune
Response to "absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury".
Oncologist, May 1, 2008; 13(5): 613 - 614.
[Full Text] [PDF]


Home page
The OncologistHome page
M. Sonmezer, H. Bang, and K. Oktay
In Reply: Can GnRH Analogues Preserve Gonadal Function Without Preserving Fertility?
Oncologist, May 1, 2008; 13(5): 615 - 617.
[Full Text] [PDF]


Home page
Am Soc Clin Oncol Ed BookHome page
K. Oktay
Fertility Preservation Options for Young Women with Cancer
ASCO Educational Book, January 1, 2008; 2008(1): 43 - 47.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
H. C. F. Moore and R. L. Theriault
Commentary: Ovarian Function Does Not Equal Fertility Does Not Equal Babies
Oncologist, September 1, 2007; 12(9): 1067 - 1069.
[Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/misc/eLetters.shtml

Copyright © 2007 by AlphaMed Press.